Macrophage phagocytosis of myelin in vitro determined by flow cytometry: Phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-α and nitric oxide

Journal of Neuroimmunology

Volumn 70, Issue 2, 1996, Pages 145-152

  Van Der Laan, Luc J W ^a   Ruuls, Sigrid R ^a   Weber, Kimberley S ^a   Lodder, Ilse J ^a   Döpp, Ed A ^a   Dijkstra, Christine D ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

CR3; Demyelination; Flow cytometry; Ingestion; Macrophage; Myelin

Indexed keywords

COMPLEMENT; COMPLEMENT RECEPTOR; EDETIC ACID; MYELIN; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEMYELINATION; FLOW CYTOMETRY; MACROPHAGE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030297701     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00110-5     Document Type: Article

References (27)

1. Baron, P., Constantin, G., Andrea, A.D. et al. (1993). Production of tumor necrosis factor and other proinflammatory cytokines by human mononuclear phagocytes stimulated with myelin P2 protein. Proc. Natl. Acad. Sci. USA 90, 4414-4418.
2. Brück, W. and Friede, R.L. (1990a). Anti-macrophage CR3 antibody blocks myelin phagocytosis by macrophages in vitro. Acta Neuropathol. 80, 415-418.
3. Brück, W. and Friede, R.L. (1990b). L-Fucosidase treatment blocks myelin phagocytosis by macrophages in vitro. J. Neuroimmunol. 27, 217-227.
4. Brück, W. and Friede, R.L. (1991). The role of complement in myelin phagocytosis during PNS Wallerian degeneration. J. Neurol. Sci. 103, 182-187.
5. Brück, W., Brück, Y. and Friede, R.L. (1992). TNF-α suppresses CR3-mediated myelin removal by macrophages. J. Neuroimmunol. 38, 9-18.
6. Compston, P.A., Scolding, N. and Noble, M. (1991). Pathogenesis of demyelinating diseases: insights from cell biology. Trends Neurosci. 14, 175-182.
7. Damoiseaux, J.G.M.C., Döpp, E.A., Neefjes, J.J., Beelen, R.H.J. and Dijkstra, C.D. (1989). Heterogeneity of macrophages in the rat evidenced by variability in determinants: two new anti-rat macrophage antibodies against a heterodimer of 160 and 95 kD (CD11/CD18). J. Leukocyte Biol. 46, 556-564.
8. Flick, D.A. and Gifford, G.E. (1984). Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J. Immunol. Meth. 68, 167-175.
9. Goldenberg, P.Z., Kwon, E.E., Benjamins, J.A. et al. (1989). Opsonization of normal myelin by anti-myelin antibodies and normal serum. J. Neuroimmunol. 23, 157-166.
10. Gordon, E.J., Myers, K.J., Dougherty, J.P., Rosen, H. and Ron, Y. (1995). Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 62, 153-160.
11. Hartung, H.-P. (1993). Immune-mediated demyelination. Ann. Neurol. 33, 563-567.
12. Huitinga, I., Van Rooijen, N., De Groot, C.J.A., Uitdehaag, B.M.J. and Dijkstra, C.D. (1990). Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J. Exp. Med. 172, 1025-1033.
13. Huitinga, I., Damoiseaux, J.G.M.C., Döpp, E.A. and Dijkstra, C.D. (1993). Treatment with anti-CR3 antibodies ED7 and ED8 supresses experimental allergic encephalomyelitis in Lewis rats. Eur. J. Immunol. 23, 709-715.
14. Huitinga, I., Ruuls, S.R., Jung, S., Van Rooijen, N., Hartung, H.-P. and Dijkstra, C.D. (1995). Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in lewis rats. Clin. Exp. Immunol. 100, 344-351.
15. Lampert, P.W. (1984). The structure of the demyelination process. In: J.F. Hallpike et al. (Eds.), Multiple sclerosis, pathology diagnosis and management. Chapman and Hall, London, pp. 29-46.
16. Linington, C., Morgan, B.P., Scolding, N.J., Wilkins, P., Piddlesden, S. and Compston, D.A.S. (1989). The role of complement in the pathogenesis of experimental allergic encephalomyelitis. Brain 112, 895-911.
17. Merrill, J.E., Ignaro, L.J., Sherman, M.P., Melinek, J. and Lane, T.E. (1993). Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151, 2132-2141.
18. Norton, W.T. and Poduslo, S.E. (1973). Myelination in rat brain: method of isolation. J. Neurochem. 21, 749-757.
19. Okuda, Y., Nakatsuji, Y., Fuijmura, H. et al. (1995). Expression of inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol. 62, 103-112.
20. Robinson, A.P., White, T.M. and Mason, D.W. (1986). Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. Immunology, 57, 239-247.
21. Ross, G.D. and Vetvicka, V. (1993). CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions. Clin. Exp. Immunol. 92, 181-184.
22. Ruddle, N.H., Bergman, C.M., McGrath, K.M., Lingenheld, E.G., Grunnet, M.L., Padula, S.J. and Clark, R.B. (1990). An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172, 1193-1200.
23. Ruuls, S.R., Bauer, J., Sontrop, K., Huitinga, I., 't Hart, B.A. and Dijkstra, C.D. (1995). Reactive oxygen species are involved in the pathogenesis ot experimental allergic encephalomyelitis in Lewis rats. J. Neuroimmunol. 56, 207-217.
24. Selmaj, K., Papierz, W., Glabinski, A. and Kohno, T. (1995). Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble TNF receptor 1. J. Neuroimmunol. 56, 135-141.
25. Selmaj, K., Zeman, A., McClean, B. and Thompson, J. (1988). Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23, 339-344.
26. Van den Berg, T.K., Döpp, E.A., Daha, M.R., Kraal, G. and Dijkstra, C.D. (1993). Selective inhibition of immune complex trapping by follicular dendritic cells with monoclonal antibodies against rat C3. Eur. J. Immunol. 22, 957-962.
27. Vanguri, P., Koski, C.L., Silverman, B. and Shin, M.L. (1982). Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies. Proc. Natl. Acad. Sci. USA 79, 3290-3294.